セッション

検索結果は4件です。

The Role of Ral in Colitis-Associated Cancer in Mice
Yoshino Takuya(Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Japan)
Background:Patients with long-term IBD are at high risk of developing colitis-associated cancer(CAC). The mechanisms of CAC were poorly understood. Small GTPase, Ral, is known to be highly activated i...

第99回日本消化器病学会総会Colitis-Associated Cancer

P53 IHC Resolves Difficulty of Pathological Diagnosis in Indefinite Lesions for Neoplasia in UC;Using Image Processing Software Analysis
Okamoto Yosuke(Department of Surgical and Molecular Pathology, Dokkyo Medical University of Medicine, Japan, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, Japan)
The incidence of colorectal neoplasia is increased in patients with long-standing and extensive ulcerative colitis(UC). To improve the prognosis of patients with UC-associated neoplasia, it is importa...

第99回日本消化器病学会総会Colitis-Associated Cancer

Serine Protease Inhibitor Kazal Type 1 Promote a Carcinogenesis of the Colon
Ida Satoshi(Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan)
<Backgrounds and Aim>Colitis-associated cancer(CAC)is the most serious complication of inflammatory bowel disease(IBD).However, the pathogenesis of CAC is still uncertain. Serine protease inhibitor Ka...

第99回日本消化器病学会総会Colitis-Associated Cancer

The Background and Clinical Course of Colitis-associated Cancer of UC Patients
Uchiyama Kazuhiko(Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Japan)
Background and Aims:In the UC patients, it has been reported that recurrent inflammation with ulceration confers an increased risk of colitis-associated cancer. In the present study, we investigated t...

第99回日本消化器病学会総会Colitis-Associated Cancer